Ours and other studies have demonstrated that TRPV1-mediated pharmacological hypothermia decreases the cortical injury and provides neuroprotection after 24 hours cerebral reperfusion in the stroke model9,13. This evidence concerns the gene TRPV1 and stroke disorder.